Antonios M. Xydakis

892 total citations
17 papers, 709 citations indexed

About

Antonios M. Xydakis is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Antonios M. Xydakis has authored 17 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 6 papers in Oncology. Recurrent topics in Antonios M. Xydakis's work include Lipoproteins and Cardiovascular Health (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Cancer, Lipids, and Metabolism (3 papers). Antonios M. Xydakis is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Cancer, Lipids, and Metabolism (3 papers). Antonios M. Xydakis collaborates with scholars based in United States, Greece and Russia. Antonios M. Xydakis's co-authors include Christie M. Ballantyne, Peter H. Jones, Ron C. Hoogeveen, E. O’Brian Smith, Christopher Case, Mine‐Yine Liu, E. O’Brian Smith, Abu R. Vasudevan, Huaizhu Wu and David B. Corry and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of the New York Academy of Sciences and The American Journal of Medicine.

In The Last Decade

Antonios M. Xydakis

17 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonios M. Xydakis United States 10 262 242 155 137 111 17 709
Yae Jung Hyun South Korea 16 283 1.1× 238 1.0× 189 1.2× 129 0.9× 87 0.8× 21 719
David Lau Canada 4 345 1.3× 237 1.0× 169 1.1× 105 0.8× 137 1.2× 8 810
Claudia Ress Austria 18 341 1.3× 266 1.1× 197 1.3× 184 1.3× 143 1.3× 32 866
Simon Dunmore United Kingdom 15 258 1.0× 281 1.2× 178 1.1× 226 1.6× 237 2.1× 32 922
Hongyun Yan Canada 5 399 1.5× 308 1.3× 172 1.1× 105 0.8× 178 1.6× 7 912
Margarita Torres‐Tamayo Mexico 14 192 0.7× 298 1.2× 233 1.5× 119 0.9× 107 1.0× 50 969
Georgios A. Christou Greece 15 199 0.8× 166 0.7× 212 1.4× 123 0.9× 151 1.4× 45 718
Wiesława Łysiak−Szydłowska Poland 18 102 0.4× 202 0.8× 145 0.9× 80 0.6× 160 1.4× 46 786
Teoman Doğru Türkiye 20 615 2.3× 160 0.7× 286 1.8× 225 1.6× 173 1.6× 47 1.1k
Gaetano Leto Italy 18 157 0.6× 216 0.9× 310 2.0× 154 1.1× 249 2.2× 35 1.1k

Countries citing papers authored by Antonios M. Xydakis

Since Specialization
Citations

This map shows the geographic impact of Antonios M. Xydakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonios M. Xydakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonios M. Xydakis more than expected).

Fields of papers citing papers by Antonios M. Xydakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonios M. Xydakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonios M. Xydakis. The network helps show where Antonios M. Xydakis may publish in the future.

Co-authorship network of co-authors of Antonios M. Xydakis

This figure shows the co-authorship network connecting the top 25 collaborators of Antonios M. Xydakis. A scholar is included among the top collaborators of Antonios M. Xydakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonios M. Xydakis. Antonios M. Xydakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Spyroglou, Ariadni, Antonios M. Xydakis, Panagiotis Kekis, et al.. (2024). The Long Journey towards Personalized Targeted Therapy in Poorly Differentiated Thyroid Carcinoma (PDTC): A Case Report and Systematic Review. Journal of Personalized Medicine. 14(6). 654–654. 3 indexed citations
2.
Xydakis, Antonios M., et al.. (2020). Adrenal Failure and Orchitis Secondary to Tuberculosis Mimicking Metastatic Malignancy. The American Journal of Medicine. 133(9). e518–e520. 4 indexed citations
3.
Alexandraki, Krystallenia, Vasiliki Mavroeidi, Georgios Kyriakopoulos, et al.. (2019). Role of Receptor Profiling for Personalized Therapy in a Patient with a Growth Hormone-Secreting Macroadenoma Resistant to First-Generation Somatostatin Analogues. Journal of Personalized Medicine. 9(4). 48–48. 4 indexed citations
4.
Stavroulopoulos, Aristeidis, et al.. (2010). Interstitial nephritis and nephrogenic diabetes insipidus in a patient treated with pemetrexed. Renal Failure. 32(8). 1000–1004. 30 indexed citations
5.
Xydakis, Antonios M., et al.. (2006). Hormone Replacement Therapy in Breast Cancer Survivors. Annals of the New York Academy of Sciences. 1092(1). 349–360. 8 indexed citations
6.
Mastorakos, George, et al.. (2006). Pitfalls of the WHIs. Annals of the New York Academy of Sciences. 1092(1). 331–340. 14 indexed citations
7.
Vasudevan, Abu R., Huaizhu Wu, Antonios M. Xydakis, et al.. (2006). Eotaxin and Obesity. The Journal of Clinical Endocrinology & Metabolism. 91(1). 256–261. 103 indexed citations
8.
Ballantyne, Christie M., et al.. (2006). Effectiveness and Tolerability of Adding Ezetimibe to Niacin-Based Regimens for Treatment of Primary Hyperlipidemia. Endocrine Practice. 12(2). 159–164. 13 indexed citations
9.
Xydakis, Antonios M., et al.. (2005). Multiplexed Analysis of Biomarkers Related to Obesity and the Metabolic Syndrome in Human Plasma, Using the Luminex-100 System. Clinical Chemistry. 51(7). 1102–1109. 150 indexed citations
10.
Xydakis, Antonios M. & Christie M. Ballantyne. (2004). Management of metabolic syndrome: statins. Endocrinology and Metabolism Clinics of North America. 33(3). 509–523. 6 indexed citations
11.
Xydakis, Antonios M., Christopher Case, Peter H. Jones, et al.. (2004). Adiponectin, Inflammation, and the Expression of the Metabolic Syndrome in Obese Individuals: The Impact of Rapid Weight Loss through Caloric Restriction. The Journal of Clinical Endocrinology & Metabolism. 89(6). 2697–2703. 228 indexed citations
12.
Xydakis, Antonios M., et al.. (2004). Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia. The American Journal of Cardiology. 94(6). 795–797. 48 indexed citations
13.
Xydakis, Antonios M. & Peter H. Jones. (2003). Toxicity of antilipidemic agents: Facts and fictions. Current Atherosclerosis Reports. 5(5). 403–410. 1 indexed citations
14.
Xydakis, Antonios M. & Christie M. Ballantyne. (2003). Role of non–high-density lipoprotein cholesterol in prevention of cardiovascular disease: updated evidence from clinical trials. Current Opinion in Cardiology. 18(6). 503–509. 19 indexed citations
15.
Xydakis, Antonios M. & Peter H. Jones. (2003). Use of statins for secondary prevention. Current Treatment Options in Cardiovascular Medicine. 5(1). 63–73. 3 indexed citations
16.
Xydakis, Antonios M., et al.. (2002). The Effect of Aspirin and Various Iontophoresis Solution Vehicles on Skin Microvascular Reactivity. Microvascular Research. 63(1). 91–95. 29 indexed citations
17.
Xydakis, Antonios M. & Christie M. Ballantyne. (2002). Combination therapy for combined dyslipidemia. The American Journal of Cardiology. 90(10). 21–29. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026